http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28246592

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 1932-6203
issueIdentifier 5
pageRange e38000-
publicationName PLoS ONE
startingPage e38000
bibliographicCitation Liu Y, Hu X, Lu T, Cheng Y, Young CYF, Yuan H, Lou H. Retigeric Acid B Exhibits Antitumor Activity through Suppression of Nuclear Factor-κB Signaling in Prostate Cancer Cells in Vitro and in Vivo. PLoS ONE. 2012 May 29;7(5):e38000. doi: 10.1371/journal.pone.0038000.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8885b41f6771bf20d168e71e02b0aa48
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4894d01be1a30d47d10af253acc9deaf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_591576008a6603a7c0c302b99ff5cba4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ba51da87defed47211592c4cc875aa0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5ca974c38c05385b6733ab3d55ed6fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af632787b513b49a0825feeab47e5b62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c288ec2855351d133e27c86443dca397
date 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/22666431
https://doi.org/10.1371/journal.pone.0038000
https://pubmed.ncbi.nlm.nih.gov/PMC3362538
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
https://portal.issn.org/resource/ISSN/1932-6203
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Retigeric Acid B Exhibits Antitumor Activity through Suppression of Nuclear Factor-κB Signaling in Prostate Cancer Cells in Vitro and in Vivo
discusses http://id.nlm.nih.gov/mesh/M0535649
http://id.nlm.nih.gov/mesh/M0022020
http://id.nlm.nih.gov/mesh/M0214240
http://id.nlm.nih.gov/mesh/M0279189
http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D051996Q000378
http://id.nlm.nih.gov/mesh/D014315Q000494
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D011471Q000473
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002465Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D021581Q000187
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D015536Q000187
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D010766Q000187
http://id.nlm.nih.gov/mesh/D017209Q000235
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D002467Q000378
http://id.nlm.nih.gov/mesh/D051550Q000378
http://id.nlm.nih.gov/mesh/D002467Q000187
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f77be2a38ebd4e1357d44f6abac2461c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53319374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fef076960906aae0e2e34f53b8e73397
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2b3a5ba99bc94e77229bab735b7776f
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2133dc5bbd310403b240105083adce84
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95421c679462609c9ef4e68005e1dcc

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135777847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322755831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128141778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127978224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129116523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136228930

Total number of triples: 70.